References

Castanon A, Ferrman S, Patnick J, Sasieni P (2012). Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers. Cytopathology 23:13-22.

Cubie HA, Cuschieri K (2013). Understanding HPV tests and their appropriate applications. Cytopathology 24:289-308.

Darragh TM, Colgan TJ, Cox JT et al. (2012). The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arc Pathol Lab Med 136:1266-97.

Galgano MT, Castle PE, Atkins KA et al. (2010). Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 3:1077-87.

Jordan J, Arbyn M, Martin-Hirsch P et al. (2008). European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology. Cytopathology 19:342-54.

Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R (1998). Colposcopy in the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 91:626-31.

Stoler MH, Schiffman M (2001). Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 285:1500-5.

Talaat A, Brinkmann D, Dhundee J et al. (2012)  Risk of significant gynaecological pathology in women with ?glandular neoplasia on cervical cytology.  Cytopathology 23:371-7.

Underwood M, Arbyn M, Parry-Smith W et al. (2012). Accuracy of colposcopy-directed punch biopsies. BJOG 119:1293-301.

Wentzensen NI, Schwartz L, Zuna RE et al. (2012). Performance of p16/Ki67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res 18: 4154-62.

X